|
US2005A
(en)
*
|
|
1841-03-16 |
|
Improvement in the manner of constructing molds for casting butt-hinges |
|
US2004A
(en)
*
|
|
1841-03-12 |
|
Improvement in the manner of constructing and propelling steam-vessels |
|
US2006A
(en)
*
|
|
1841-03-16 |
|
Clamp for crimping leather |
|
US4331647A
(en)
|
1980-03-03 |
1982-05-25 |
Goldenberg Milton David |
Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers
|
|
US4376110A
(en)
|
1980-08-04 |
1983-03-08 |
Hybritech, Incorporated |
Immunometric assays using monoclonal antibodies
|
|
US4603044A
(en)
|
1983-01-06 |
1986-07-29 |
Technology Unlimited, Inc. |
Hepatocyte Directed Vesicle delivery system
|
|
EP0216846B2
(en)
|
1985-04-01 |
1995-04-26 |
Celltech Limited |
Transformed myeloma cell-line and a process for the expression of a gene coding for a eukaryotic polypeptide employing same
|
|
GB8601597D0
(en)
|
1986-01-23 |
1986-02-26 |
Wilson R H |
Nucleotide sequences
|
|
US5260203A
(en)
|
1986-09-02 |
1993-11-09 |
Enzon, Inc. |
Single polypeptide chain binding molecules
|
|
EP0281604B1
(en)
|
1986-09-02 |
1993-03-31 |
Enzon Labs Inc. |
Single polypeptide chain binding molecules
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
GB8717430D0
(en)
|
1987-07-23 |
1987-08-26 |
Celltech Ltd |
Recombinant dna product
|
|
US5567584A
(en)
|
1988-01-22 |
1996-10-22 |
Zymogenetics, Inc. |
Methods of using biologically active dimerized polypeptide fusions to detect PDGF
|
|
DE68926888T2
(de)
|
1988-01-22 |
1997-01-09 |
Zymogenetics Inc |
Verfahren zur Herstellung von sekretierten Rezeptoranalogen
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
EP0436597B1
(en)
|
1988-09-02 |
1997-04-02 |
Protein Engineering Corporation |
Generation and selection of recombinant varied binding proteins
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
DE3920358A1
(de)
|
1989-06-22 |
1991-01-17 |
Behringwerke Ag |
Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
|
|
US5413923A
(en)
|
1989-07-25 |
1995-05-09 |
Cell Genesys, Inc. |
Homologous recombination for universal donor cells and chimeric mammalian hosts
|
|
US5780225A
(en)
|
1990-01-12 |
1998-07-14 |
Stratagene |
Method for generating libaries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules
|
|
AU7247191A
(en)
|
1990-01-11 |
1991-08-05 |
Molecular Affinities Corporation |
Production of antibodies using gene libraries
|
|
WO1996033735A1
(en)
|
1995-04-27 |
1996-10-31 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
DE69120146T2
(de)
|
1990-01-12 |
1996-12-12 |
Cell Genesys Inc |
Erzeugung xenogener antikörper
|
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
|
EP0462815B1
(en)
|
1990-06-21 |
1996-09-25 |
Honeywell Inc. |
Receding horizon based adaptive control having means for minimizing operating costs
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
ATE158021T1
(de)
|
1990-08-29 |
1997-09-15 |
Genpharm Int |
Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5814318A
(en)
|
1990-08-29 |
1998-09-29 |
Genpharm International Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5698426A
(en)
|
1990-09-28 |
1997-12-16 |
Ixsys, Incorporated |
Surface expression libraries of heteromeric receptors
|
|
CA2095633C
(en)
|
1990-12-03 |
2003-02-04 |
Lisa J. Garrard |
Enrichment method for variant proteins with altered binding properties
|
|
ATE414768T1
(de)
|
1991-04-10 |
2008-12-15 |
Scripps Research Inst |
Bibliotheken heterodimerer rezeptoren mittels phagemiden
|
|
WO1992022324A1
(en)
|
1991-06-14 |
1992-12-23 |
Xoma Corporation |
Microbially-produced antibody fragments and their conjugates
|
|
ATE207080T1
(de)
|
1991-11-25 |
2001-11-15 |
Enzon Inc |
Multivalente antigen-bindende proteine
|
|
PT1024191E
(pt)
|
1991-12-02 |
2008-12-22 |
Medical Res Council |
Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos
|
|
US5733743A
(en)
|
1992-03-24 |
1998-03-31 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
|
WO1995015982A2
(en)
|
1993-12-08 |
1995-06-15 |
Genzyme Corporation |
Process for generating specific antibodies
|
|
DE69534347T2
(de)
|
1994-01-31 |
2006-05-24 |
Trustees Of Boston University, Boston |
Bibliotheken aus Polyklonalen Antikörpern
|
|
US5516637A
(en)
|
1994-06-10 |
1996-05-14 |
Dade International Inc. |
Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage
|
|
WO1996034096A1
(en)
|
1995-04-28 |
1996-10-31 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
JP2978435B2
(ja)
|
1996-01-24 |
1999-11-15 |
チッソ株式会社 |
アクリロキシプロピルシランの製造方法
|
|
JP4046354B2
(ja)
|
1996-03-18 |
2008-02-13 |
ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム |
増大した半減期を有する免疫グロブリン様ドメイン
|
|
CA2722378C
(en)
|
1996-12-03 |
2015-02-03 |
Amgen Fremont Inc. |
Human antibodies that bind tnf.alpha.
|
|
TWI239847B
(en)
*
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
|
US6057127A
(en)
*
|
1998-01-29 |
2000-05-02 |
Heska Corporation |
Equine Fc epsilon receptor alpha chain nucleic acid molecules and uses thereof
|
|
US6057128A
(en)
*
|
1998-03-17 |
2000-05-02 |
Genetics Institute, Inc. |
MU-1, member of the cytokine receptor family
|
|
US7198789B2
(en)
*
|
1998-03-17 |
2007-04-03 |
Genetics Institute, Llc |
Methods and compositions for modulating interleukin-21 receptor activity
|
|
EP1082433A4
(en)
*
|
1998-05-29 |
2003-01-02 |
Human Genome Sciences Inc |
Interleukins 21 and 22
|
|
US20010023070A1
(en)
|
1998-05-29 |
2001-09-20 |
Reinhard Ebner |
Interleukins-21 and 22
|
|
US6682736B1
(en)
|
1998-12-23 |
2004-01-27 |
Abgenix, Inc. |
Human monoclonal antibodies to CTLA-4
|
|
US6307024B1
(en)
|
1999-03-09 |
2001-10-23 |
Zymogenetics, Inc. |
Cytokine zalpha11 Ligand
|
|
KR100743640B1
(ko)
*
|
1999-03-09 |
2007-07-27 |
지모제넥틱스, 인코포레이티드 |
신규한 사이토킨 ｚａｌｐｈａ 11 리간드
|
|
US7135287B1
(en)
|
1999-10-02 |
2006-11-14 |
Biosite, Inc. |
Human antibodies
|
|
ES2279809T3
(es)
|
2000-04-05 |
2007-09-01 |
Zymogenetics, Inc. |
Receptores de citoquina zalfa11 solubles.
|
|
EP1332209B1
(en)
|
2000-09-08 |
2009-11-11 |
Universität Zürich |
Collections of repeat proteins comprising repeat modules
|
|
DE10047189C1
(de)
|
2000-09-23 |
2002-02-21 |
Bosch Gmbh Robert |
Verfahren zur Insassenklassifikation mit einer Sitzmatte im Fahrzeugsitz
|
|
US7083784B2
(en)
|
2000-12-12 |
2006-08-01 |
Medimmune, Inc. |
Molecules with extended half-lives, compositions and uses thereof
|
|
ES2334338T3
(es)
*
|
2001-11-05 |
2010-03-09 |
Zymogenetics, Inc. |
Antagonistas de il-21.
|
|
US20040028665A1
(en)
|
2002-01-08 |
2004-02-12 |
Garner Bryan E. |
Compositions and methods for inhibiting pathogenic growth
|
|
CA2481304A1
(en)
|
2002-03-27 |
2003-10-09 |
Patrick Hwu |
Method for treating cancer in humans
|
|
WO2003087320A2
(en)
|
2002-04-09 |
2003-10-23 |
Beth Israel Deaconess Medical Center, Inc. |
Antagonists of il-21 and modulation of il-21-mediated t cell responses
|
|
US20040016010A1
(en)
*
|
2002-04-17 |
2004-01-22 |
Marion Kasaian |
IL-21 receptor knockout animal and methods of use thereof
|
|
DK1531850T3
(da)
|
2002-06-07 |
2012-06-04 |
Zymogenetics Inc |
Anvendelse af 1L-21 og monoklonalt antistof til behandling af solide cancere
|
|
AU2003251633A1
(en)
|
2002-07-01 |
2004-01-19 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of |
Il-21 as a regulator of immunoglobin production
|
|
US7314623B2
(en)
*
|
2002-07-15 |
2008-01-01 |
Wyeth |
Methods and compositions for modulating T helper (Th) cell development and function
|
|
CN101972478B
(zh)
|
2002-10-08 |
2012-10-31 |
免疫医疗公司 |
抗体治疗
|
|
US20070092485A1
(en)
|
2002-11-15 |
2007-04-26 |
Zymogenetics, Inc. |
Cytokine zalpha11 ligand
|
|
JP3979276B2
(ja)
*
|
2002-11-29 |
2007-09-19 |
富士通株式会社 |
業務支援方法、業務支援装置、及びプログラム
|
|
EP1573006B1
(en)
|
2002-12-13 |
2009-11-11 |
ZymoGenetics, Inc. |
Il-21 production in prokaryotic hosts
|
|
EP1575615A1
(en)
|
2002-12-23 |
2005-09-21 |
Innate Pharma |
Pharmaceutical compositions having an effect on the proliferation of nk cells and a method using the same
|
|
NZ542306A
(en)
*
|
2003-03-14 |
2008-04-30 |
Wyeth Corp |
Antibodies against human IL-21 receptor and uses therefor
|
|
CA2518854A1
(en)
*
|
2003-03-21 |
2004-10-07 |
Wyeth |
Treating immunological disorder using agonists of interleukin-21/interleukin-21 receptor
|
|
JP2007508332A
(ja)
|
2003-10-17 |
2007-04-05 |
ノボ ノルディスク アクティーゼルスカブ |
併用療法
|
|
JP4471721B2
(ja)
|
2004-04-20 |
2010-06-02 |
独立行政法人産業技術総合研究所 |
抗インターロイキン２１受容体（ｉｌ−２１ｒ）抗体および本抗体を産生するハイブリドーマ
|
|
EP1753458A4
(en)
*
|
2004-05-19 |
2009-07-22 |
Wyeth Corp |
MODULATION OF IMMUNOGLOBULIN PRODUCTION AND ATOPIC DISORDERS
|
|
US20060008844A1
(en)
|
2004-06-17 |
2006-01-12 |
Avidia Research Institute |
c-Met kinase binding proteins
|
|
RU2007102287A
(ru)
*
|
2004-08-05 |
2008-09-10 |
Вайет (Us) |
Антагонисты активности рецептора интерлейкина-21
|
|
ITRM20040586A1
(it)
*
|
2004-11-29 |
2005-02-28 |
Giuliani Spa |
Epitopi antigenici dell'interleuchina-21, anticorpi relativi e loro uso in campo medico.
|
|
WO2006105538A2
(en)
|
2005-03-31 |
2006-10-05 |
Centocor, Inc. |
Methods and compositions for treating il-21 related pathologies
|
|
DK200501310A
(da)
|
2005-09-21 |
2005-10-01 |
Novo Nordisk As |
The invention relates to the treatment or prevention of autoimmune diseases and latent autoimmune diabetes in the adults
|
|
WO2007111714A2
(en)
|
2005-11-28 |
2007-10-04 |
Zymogenetics, Inc. |
Il-21 antagonists
|
|
WO2007114861A2
(en)
*
|
2005-11-28 |
2007-10-11 |
Zymogenetics, Inc. |
Il-21 receptor antagonists
|
|
US7883700B2
(en)
|
2007-12-07 |
2011-02-08 |
Zymogenetics, Inc. |
Anti-human IL-21 monoclonal antibodies
|
|
WO2009132821A1
(en)
|
2008-04-28 |
2009-11-05 |
Giuliani International Limited |
Interleukin (il-21) binding proteins and methods of making and using same
|
|
WO2012098113A1
(en)
|
2011-01-17 |
2012-07-26 |
Novo Nordisk A/S |
Il-21 ligands
|